Skip to main content

Table 2 Number of individuals fully vaccinated (2 doses + 2 weeks) in initial priority groups in OpenSAFELY-TPP, and number and rate with each outcome

From: Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY

Priority group

Fully vaccinated

Positive SARS-CoV-2 testa

COVID-19-related hospital admissiona

COVID-19-related critical care admissionaa

COVID-19-related deatha

Countb

Follow-up time, medium days (IQR)

Tests conducted (%)c

Positivity (%)

Eventsb (PYs)

Incidence rate per 1000 person-years (95% CI)

Eventsb (PYs)

Incidence rate per 1000 person-years (95% CI)

Eventsb (PYs)

Incidence rate per 1000 person-years (95% CI)

Eventsb (PYs)

Incidence rate per 1000 person-years (95% CI)

0

1

2

3+

All

15,501,550

149 (107–179)

46

19

10

19

579,780 (5,912,498)

3.17

98.06 (97.93–98.19)

28,580 (,5993,535)

4.77 (4.74–4.8)

1980 (5996007)

0.33 (0.32–0.34)

6435 (5,996,178)

1.07 (1.06–1.09)

Care home

(priority group 1)

98,400

200 (180–207)

9

5

4

82

3110 (48,207)

0.90

64.51 (63.37–65.68)

755 (48,600)

15.58 (15.02–16.15)

REDACTED

REDACTED

650 (48,674)

13.37 (12.86–13.91)

80+

(priority group 2)

1,073,145

200 (191–213)

59

14

7

20

15,945 (597,368)

1.96

26.69 (26.48–26.9)

7545 (598,868)

12.60 (12.45–12.74)

180 (599,613)

0.30 (0.28–0.32)

2785 (599,626)

4.64 (4.56–4.73)

Health/care workers

(priority groups 1–2)

555,820

200 (182–211)

27

21

14

39

30,045 (282,813)

3.31

106.23 (105.62–106.84)

440 (287,822)

1.53 (1.46–1.60)

30 (287,862)

0.10 (0.08–0.12)

20 (287,866)

0.07 (0.05–0.08)

70–79

(priority groups 3–4)

1,990,755

184 (176–191)

56

17

8

19

41,325 (985,544)

2.16

41.93 (41.73–42.14)

6875 (990,497)

6.94 (6.86–7.03)

525 (991,111)

0.53 (0.51–0.56)

1640 (991,147)

1.66 (1.62–1.70)

CEV (age 16–69)

(priority group 4)

725,045

171 (157–181)

42

18

10

30

34,820 (322,885)

2.92

107.84 (107.27–108.42)

4560 (327,932)

13.90 (13.7–14.11)

565 (328,308)

1.73 (1.66–1.80)

785 (328,361)

2.39 (2.31–2.48)

50–69

(priority groups 5–9)

4,730,155

151 (138–166)

47

18

9

26

184,890 (1,946,451)

2.27

94.99 (94.77–95.21)

5075 (1,973,346)

2.57 (2.54–2.61)

515 (1,973,743)

0.26 (0.25–0.27)

495 (1,973,791)

0.25 (0.24–0.26)

Others not in the above groupsd

15,501,550

149 (107–179)

46

19

10

19

579,780 (5,912,498)

3.17

98.06 (97.93–98.19)

28,580 (5,993,535)

4.77 (4.74–4.80)

1980 (5,996,007)

0.33 (0.32–0.34)

6435 (5,996,178)

1.07 (1.06–1.09)

  1. CEV clinically extremely vulnerable.  aAll outcomes calculated as of 01st November 2021. bAll counts (of people and events) have been rounded to the nearest 5 and counts. cTests conducted is a count of (positive and negative) test results and may include multiple tests for an individual person. dOthers includes: others in priority groups (“At Risk”), some misclassified health/care workers and care home residents (except those age 70+ or shielding who will be included in another group), carers, household contacts of those at increased risk, and those not in priority groups who had the vaccine opportunistically, e.g., by responding to calls to use up excess doses